We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$19.9B
AUM Growth
+$3.15B
(+19%)
Cap. Flow
+$2.87B
Cap. Flow
% of AUM
14.37%
Top 10 Holdings %
Top 10 Hldgs %
18.32%
Holding
1,356
New
166
Increased
640
Reduced
325
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$179M |
| 2 |
Amazon
AMZN
|
+$121M |
| 3 |
Alibaba
BABA
|
+$111M |
| 4 |
Merck
MRK
|
+$94.9M |
| 5 |
Comcast
CMCSA
|
+$78.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$88.1M |
| 2 |
Cisco
CSCO
|
+$82.5M |
| 3 |
NextEra Energy
NEE
|
+$74.9M |
| 4 |
Union Pacific
UNP
|
+$52M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$46.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Healthcare | 17.64% |
| 3 | Financials | 13.64% |
| 4 | Communication Services | 10.78% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
U-Haul Holding Co
UHAL
$14.6B
| $390K | ﹤0.01% |
10,040
+4,190
| +72% | +$160K |
|
952
Kura Oncology
KURA
$850M
| $388K | ﹤0.01% |
19,600
+7,600
| +63% | +$126K |
|
953
EastGroup Properties
EGP
$10.9B
| $378K | ﹤0.01% |
3,324
| – | – |
|
954
Fluor
FLR
$7.96B
| $372K | ﹤0.01% |
10,717
-667
| -6% | -$22.3K |
|
955
Chemours
CC
$2.37B
| $361K | ﹤0.01% |
14,158
-9,480
| -40% | -$279K |
|
956
Melco Resorts & Entertainment
MLCO
$2.14B
| $359K | ﹤0.01% |
16,425
-3,575
| -18% | -$81.1K |
|
957
TherapeuticsMD
TXMD
$24M
| $359K | ﹤0.01% |
2,860
+1,110
| +63% | +$199K |
|
|
ADAP
958
DELISTED
Adaptimmune Therapeutics
ADAP
| $355K | ﹤0.01% |
89,000
+64,500
| +263% | +$263K |
|
959
Minerva Neurosciences
NERV
$199M
| $355K | ﹤0.01% |
+8,125
| New | +$407K |
|
960
Atlassian
TEAM
$37.8B
| $349K | ﹤0.01% |
+2,667
| New | +$321K |
|
961
Criteo S.A. Ordinary Shares
CRTO
$923M
| $342K | ﹤0.01% |
20,000
-22,852
| -53% | -$449K |
|
962
American Airlines Group
AAL
$10.6B
| $340K | ﹤0.01% |
10,176
+3,333
| +49% | +$108K |
|
963
Regenxbio
RGNX
$708M
| $338K | ﹤0.01% |
6,800
-16,900
| -71% | -$844K |
|
964
Chewy
CHWY
$9.63B
| $333K | ﹤0.01% |
+10,000
| New | +$338K |
|
|
DBVT
965
DBV Technologies
DBVT
$847M
| $325K | ﹤0.01% |
4,080
+3,840
| +1,600% | +$343K |
|
|
PDLI
966
DELISTED
PDL BioPharma, Inc.
PDLI
| $317K | ﹤0.01% |
103,800
-57,810
| -36% | -$188K |
|
967
Theravance Biopharma
TBPH
$877M
| $306K | ﹤0.01% |
19,200
+7,500
| +64% | +$152K |
|
|
SWN
968
DELISTED
Southwestern Energy Company
SWN
| $304K | ﹤0.01% |
99,306
-5,743
| -5% | -$22.3K |
|
|
TTM
969
DELISTED
Tata Motors Limited
TTM
| $302K | ﹤0.01% |
25,370
-1,300
| -5% | -$17.7K |
|
970
HEICO Corp
HEI
$51.4B
| $298K | ﹤0.01% |
+2,099
| New | +$233K |
|
|
CCXI
971
DELISTED
ChemoCentryx, Inc.
CCXI
| $295K | ﹤0.01% |
33,000
+13,000
| +65% | +$150K |
|
|
FLXN
972
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $294K | ﹤0.01% |
25,000
+9,700
| +63% | +$112K |
|
|
LSXMA
973
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $293K | ﹤0.01% |
10,380
-31,289
| -75% | -$865K |
|
|
DOVA
974
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $293K | ﹤0.01% |
21,800
+8,500
| +64% | +$80.8K |
|
975
Atara Biotherapeutics
ATRA
$76.1M
| $292K | ﹤0.01% |
576
+224
| +64% | +$158K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2019 Portfolio in Review
As of Q2 2019, DekaBank Deutsche Girozentrale held 1,356 positions worth $19.9B, up 19% from $16.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
DekaBank Deutsche Girozentrale deployed $2.87B of net new capital in Q2 2019, opening 166 new positions and adding to 640 existing holdings. Its largest new stake was Alcon: 743,373 shares worth $45.4M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was TSMC, an estimated $88.1M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2019 buy was Alcon: 743,373 shares worth $45.4M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q2 2019, an estimated $179M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2019 reduction was TSMC, cutting an estimated $88.1M.
- DekaBank Deutsche Girozentrale fully exited Express Scripts Holding Company in Q2 2019, selling an estimated $46.5M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 18% of its $19.9B portfolio in Q2 2019.
- DekaBank Deutsche Girozentrale opened 166 new positions and closed 204 in Q2 2019.
- DekaBank Deutsche Girozentrale's portfolio value rose 19% quarter-over-quarter to $19.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2019, filed 1 Aug 2019.